# Creating and sensing asymmetric lipid distributions throughout the cell

Guillaume Drin

► To cite this version:

Guillaume Drin. Creating and sensing asymmetric lipid distributions throughout the cell. Emerging Topics in Life Sciences, 2023, 7 (1), pp.7-19. 10.1042/ETLS20220028. hal-04283017

HAL Id: hal-04283017

https://hal.science/hal-04283017v1

Submitted on 13 Nov 2023

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
<figure><img src="image_2.png" /></figure>

<figure><img src="image_3.png" /></figure>

## Review Article

# Creating and sensing asymmetric lipid distributions throughout the cell

<figure><img src="image_4.png" /></figure>

Guillaume Drin

Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Valbonne, France

**Correspondence:** Guillaume Drin (drin@ipmc.cnrs.fr)

<figure><img src="image_5.png" /></figure>

A key feature of eukaryotic cells is the asymmetric distribution of lipids along their secretory pathway. Because of the biological significance of these asymmetries, it is crucial to define the mechanisms which create them. Extensive studies have led to the identification of lipid transfer proteins (LTPs) that work with lipid-synthesizing enzymes to carry lipids between two distinct membranes in a directional manner, and are thus able to create asymmetries in lipid distribution throughout the cell. These networks are often in contact sites where two organelle membranes are in close proximity for reasons we have only recently started to understand. A question is whether these networks transfer lipids *en masse* within the cells or adjust the lipid composition of organelle membranes. Finally, recent data have confirmed that some networks organized around LTPs do not generate lipid asymmetries between membranes but sense them and rectify the lipid content of the cell.

## Key lipids are asymmetrically distributed in the cell

Eukaryotic cells have a compartmentalized architecture based on membranes composed of lipids and proteins. These lipids are very diverse but mostly belong to three classes: phospholipids, sphingolipids and sterols. In addition to serving as building-blocks — they organize into bilayers to constitute the cellular membranes — lipids play functional roles through interactions with specialized proteins. All are precisely distributed between the plasma membrane (PM), which is the limiting membrane of the cell, and the membranes that delimit its internal compartments i.e. organelles like the endoplasmic reticulum (ER) or Golgi apparatus [1,2]. A general hallmark of eukaryotic cells is the asymmetric distribution of different lipids along the secretory pathway, i.e. between a region corresponding to the ER and cis-Golgi and a region comprising the trans-Golgi, endosomes and the PM (Figure 1). This defines two membrane territories with different lipid composition and contrasting features, in terms of both fluidity, thickness and surface charge [1,2]. As a consequence, these territories can harbour specific molecular mechanisms that ensure local signalling pathways, protein exchange between organelles via particular vesicular trafficking routes, and the organization of the cortical cytoskeleton. What are the nature and specific roles of the lipids that are asymmetrically distributed?

Known examples are sterols and sphingolipids, which represent, respectively, ~12–20% and 7.5–10% of membrane lipids in eukaryotic cells [3,4]. Sterol accounts for less than 5% of lipids in the ER but 10% in the trans-Golgi membrane and up to 40% in the PM [5–8]. Similar concentration gradients of sphingolipids have been observed [5,8]. This co-distribution of sterol and sphingolipids is critical for the cells, notably because, as they associate preferentially, these lipids increase the rigidity and thickness of membranes in which they are abundant [9]. This allows the PM to form an impermeable barrier between the cell interior and the external milieu but also to have a precise inner organization [10].

Another lipid is phosphatidylserine (PS), a negatively charged phospholipid species that accounts for 2–10% of cellular lipids [3,4,11]. In the ER membrane, its proportion among lipids is 3–7%, and is multiplied by 4–5 in the PM [6,12,13]. PS mostly concentrates in the inner layer of this membrane where it contributes negative charges and recruits cytosolic proteins with signalling functions via electrostatic interactions [14,15]. The last examples are phosphoinositides, a group of seven phospholipid

Received: 31 August 2022
Revised: 24 October 2022
Accepted: 1 November 2022

Version of Record published:
14 November 2022
species that represent ~1–2% of lipids and derive from phosphatidylinositol (PI). They are absent from the ER and are mostly found in the trans-Golgi and endosomal membrane, and the PM, where they play pivotal roles in vesicular trafficking, cytoskeleton organization or signalling pathways [16,17].

Considerable efforts have been made to explain the origins of these asymmetries in lipid distribution. One goal is to understand how lipid species are enriched in the trans-Golgi or PM while being partially or entirely created in the ER. Another aim is to define how these asymmetries are maintained despite the bulk exchange of lipids between organelles by vesicular trafficking, but also fast lipid enzymatic conversion and uptake.

## How are intracellular lipid asymmetries created?

Current data suggest that lipid asymmetry within cells is at least partially created by small networks composed of lipid-synthesizing enzymes, located in distinct cellular membranes, and lipid transfer proteins (LTPs) that flow lipids between these membranes. LTPs belong to diverse families, but all have a domain with a cavity to encapsulate one or several lipids [18,19]. This allows these proteins to extract lipids from an organelle membrane and shield these hydrophobic molecules from the aqueous medium (i.e. cytosol) for delivery to a second membrane. Remarkably, these networks are often organized around contact sites where the membranes of two distinct organelles are less than 30 nm apart [20], which is an extremely short distance at the cellular scale.

A known network is at the core of sphingolipid asymmetry in human cells. It involves enzymes that synthesize a lipid called ceramide in the ER and an enzyme that converts ceramide into sphingomyelin in the Golgi membrane. Ceramide travels from the ER to the Golgi via CERT, an LTP present in contact sites between these organelles [21]. CERT could move ceramide bidirectionally between the two membranes, but the metabolic trapping of ceramide, i.e. its conversion into sphingomyelin creates the conditions for a one-way transfer. Indeed, there is always more ceramide in the ER than in the Golgi membrane and, following the law of mass action, CERT picks up ceramide where is it abundant to release it where it is scarce (Figure 2a).

Other networks that generate asymmetry involve LTPs with a lipid exchange activity (ORPs in humans, Osh proteins in yeast). They have different molecular configurations, but all comprise a domain called ORD (OSBP-related domain) with a lipid-binding pocket [22]. Biochemical studies have revealed that Osh4, a representative member of this protein family, consisting only of an ORD, could host either a molecule of ergosterol [23] (i.e. main yeast sterol) or PI4P [24]. This enables Osh4 to exchange these ligands between two membranes [24,25]. Like other phosphoinositides, the intracellular distribution of PI4P is programmed by the organelle-specific localization of enzymes involved in its synthesis and degradation [16,17]. In the trans-Golgi membrane and the PM, PI 4-kinases add a phosphate group to PI to form PI4P, whereas in the ER the Sac1 protein hydrolyzes the bulk of PI4P into PI. Thus PI4P is mostly present in the trans-Golgi and PM, where it serves as a molecular signpost, but another consequence is that PI4P concentration gradients are created between these compartments and the ER. Data obtained with Osh4 have suggested a scenario in which this PI4P asymmetry is used by this protein to generate a sterol asymmetry [24].

In this model, Osh4 extracts a sterol molecule from the ER membrane in which the lipid is synthesized. Then it exchanges sterol for PI4P at the trans-Golgi, carries PI4P to the ER and takes another molecule of sterol. The maintenance of a PI4P gradient by the Golgi PI 4-kinase and Sac1 allows for multiple exchange cycles and the build-up of sterol in the Golgi membrane (Figure 2b). *In vitro* assays have supported this idea, first by showing that Osh4 transfers sterol and PI4P along opposite routes at maximal speed when these lipid ligands are in two distinct membranes; this is because Osh4 preferentially unloads a ligand in a membrane in which the second ligand is present. Perhaps more importantly, this has revealed that Osh4 could generate a sterol gradient between these membranes by dissipating a PI4P gradient [25]. Subsequent cellular studies on OSBP, the founding member of the ORP/Osh family, have endorsed this model, showing that OSBP plays a substantial role in building asymmetric sterol distribution by sterol/PI4P exchange [26,27]. Observations that the absence of Sac1 results in the accumulation of PI4P in the ER have further supported this model [28].

Startlingly, a similar exchange process contributes to PS asymmetry in cells. Like sterol, PS originates from the ER [15] and concentrates in the PM. How this was accomplished was hardly known [13] until the finding that Osh6 and Osh7 were PS/PI4P exchangers [29,30]. In yeast cells, these proteins harness the asymmetry in PI4P at the ER/PM interface to supply the PM with PS (Figure 2c). In human cells, ORP5 and ORP8 perform the same function [31]. The fact that PI4P requires energy to be synthesized (i.e. ATP) and is consumed in exchange cycles has led us to consider PI4P as a universal ‘fuel’ used by ORP/Osh proteins to create diverse lipid asymmetries throughout the eukaryotic cells [32].
<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /><figcaption>**Figure 1.** Asymmetric distribution of major lipids in the cell.</figcaption></figure>

Sterols like cholesterol are rigid and highly hydrophobic molecules made of four fused rings that possess an alcohol function and a short carbon chain. Sphingolipids, like sphingomyelin, and phospholipids (PS, PI4P and PIP₂) are composed of a polar head and two carbon chains, which are hydrophobic and flexible. In this representation of a human cell, membranes that contain most of each type of lipid are coloured (blue: cholesterol; black: sphingomyelin; pink-red: phosphatidylserine; orange: PI4P; purple: PIP₂). The asymmetries in sterol, sphingolipid, PS and phosphoinositide distributions overlap, which allows the ER/cis-Golgi and trans-Golgi/PM regions to constitute two membrane territories in the cell with contrasting features. Endo: endosome; Lys: lysosome; Mit: mitochondrion; PM: plasma membrane.

Thus, the combination of lipid transfer with lipid conversion events allows establishing one-way fluxes of lipids between membranes and create lipid asymmetries. Besides this, the features of organelle membranes likely play significant roles. The ER membrane is fluid and mostly organized into tubules, and is, therefore, highly curved [33]. These characteristics might augment the propensity of lipids to leave the ER membrane and be extracted by LTPs, as suggested *in vitro* for sterol and phospholipids [25,34,35]. Also, interestingly, some LTPs specifically localize on highly curved areas of the ER membrane [36,37]. In contrast, in the trans-Golgi membrane and the PM, the privileged association of sterol with sphingolipid presumably acts as a thermodynamic trap that prevents any sterol return to the ER [38]. Corroborating this idea, kinetic assays have shown that the delivery of sterol by sterol/PI4P exchange is enhanced in sphingolipid-rich membranes [25]. It is not clear whether sterol, which can associate laterally with PS in the PM [39,40], promotes the enrichment of this membrane with PS supplied by an ORP/Osh-mediated exchange [41].
<figure><img src="image_8.png" /></figure>

<figure><img src="image_9.png" /></figure>

<figure><img src="image_10.png" /><figcaption>**Figure 2. Protein networks that create an asymmetric distribution of lipids between membranes.**</figcaption></figure>

(a) CERT engages ER-Golgi contacts by associating with PI4P present in the trans-Golgi membrane via its PH domain and by binding to the ER-resident VAP receptor via an FFAT motif. Then, CERT carries ceramide (Cer) by means of its START domain between the two organelle membranes. Ceramide is converted into sphingomyelin (SM) by the Golgi SMS1 enzyme. Phosphatidylcholine (PC) is used as the donor of the phosphocholine head group in this catalyzed reaction in which diacylglycerol (DAG) is also produced. This metabolic trapping event enables an ER-to-Golgi transfer of ceramide and the creation of an asymmetry in sphingolipid distribution. (b) In yeast, ergosterol (ERG) is produced in the ER. In this model, Osh4 conveys ergosterol from the ER to the trans-Golgi, and PI4P along the opposite direction. A PI 4-kinase called Pik1 transforms PI into PI4P in an ATP-dependent manner in the Golgi membrane, while Sac1 hydrolyzes PI4P at the ER thereby maintaining a PI4P gradient at the ER/Golgi interface. This allows for multiple cycles of exchange and thus the build-up of ergosterol in the Golgi membrane at the expense of the ER, leading to the creation of an asymmetry (gradient) in sterol between these organelles. (c) Phosphatidyserine (PS) is produced in the ER membrane by an enzyme called Cho1. PS is then transferred by Osh6 and Osh7 to the PM by harnessing a PI4P gradient sustained by the PI 4-kinase Stt4 and Sac1, which creates an asymmetry in PS distribution (i.e. a PS gradient).
<figure><img src="image_11.png" /></figure>

# Why are LTPs located at membrane contact sites?

Many LTPs involved in lipid asymmetries are in contact sites for reasons that remain enigmatic. Possibly, the narrow gap between organelles allows for optimal transfer speed, but this idea is disputed and has rarely been addressed experimentally [42]. More likely, this LTP presence at contact sites guarantees local coupling between processes that make/modify lipids and those that transfer them, and, obviously, a high degree of accuracy, as lipids cannot be delivered *by mistake* to another organelle. Quite certainly, this serves to establish mechanisms that regulate lipid fluxes. The major one is a negative feedback loop encoded in the structure of many LTPs, that controls how long these proteins stay in contact sites and transfer lipids. First evidence has been provided by studies of OSBP in ER-Golgi contacts.

OSBP is a sterol/PI4P exchanger more complex than Osh4 that can connect the ER with the trans-Golgi membrane in addition to transferring lipids (Figure 3a); it comprises a short amino-acid motif to bind with the ER-resident protein VAPs [43] and a structural domain called PH (Pleckstrin Homology) to dock onto the trans-Golgi by recognizing PI4P [44]. It is surprising that OSBP depends on PI4P to associate with the Golgi membrane while having the ability to extract and transfer this lipid. This is in fact critical to implement a negative feedback loop that controls lipid transfer at ER-Golgi contacts [26]. As long as PI4P is available in the Golgi membrane, OSBP forms ER-Golgi contacts and exchanges PI4P for sterol, leading to the accumulation

<figure><img src="image_12.png" /><figcaption>**Figure 3. Vectorial lipid transfer at membrane contact sites.**</figcaption></figure>

(a) OSBP binds to PI4P and the small G protein Arf1 localized at the surface of the Golgi membrane via its PH domain and to the VAP receptors via its FFAT motif. OSBP can thus form ER-Golgi contact sites and deliver cholesterol (CLR) in the Golgi membrane by sterol/PI4P exchange, but also promote the recruitment of CERT. This one delivers ceramide to the trans-Golgi, which leads to the synthesis of SM and DAG. The accumulation of DAG and sterol enhances PI4P synthesis through diverse mechanisms. DAG negatively regulates the association of OSBP and CERT with the Golgi membrane. The consumption of PI4P and the production of DAG eventually trigger the disassembly of ER-Golgi contacts, which stops both sterol transfer and SM production. (b) Osh2 is in ER-PM contact sites in association with Myo5, and delivers ergosterol at endocytic sites by sterol/PI4P exchange. (c) ORP10 is in ER-endosome contact sites and delivers PS to the endosomal membrane by PS/PI4P exchange, which promotes the recruitment of EHD1 protein. Intriguingly, ORP10 is attached to the ER by forming a heterodimer with the sterol-binding protein ORP9 in complex with VAP. The functional meaning of such a partnership is not completely understood.
of cholesterol in the Golgi membrane. Once PI4P is exhausted, due to its transfer to the ER and hydrolysis by Sac1, OSBP dissociates from the Golgi membrane, exits contact sites and becomes inactive.

Moreover, via its exchange activity, OSBP controls the transfer activity of CERT, which also depends on PI4P to populate ER-Golgi contacts and be operative [45]. Consequently, the ceramide and cholesterol flows are synchronized, allowing for a strict control of the sterol/sphingolipid balance in the Golgi apparatus. Additional processes tightly regulate these flows. Notably, the accumulation in the Golgi membrane of sterol and DAG, a by-product of sphingomyelin synthesis, modulates both the synthesis of PI4P and the activities of CERT and OSBP [27,45–51]. OSBP must be spatially close to PI 4-kinases; otherwise lipid exchange is decoupled from PI4P synthesis, which results in uncontrolled PI4P waves along the Golgi apparatus and aberrant dynamics in ER-Golgi contacts formation [27]. Also, Sac1 associates with OSBP in complex with VAP [52]. Thus, in ER-Golgi contacts, OSBP and CERT are confined together with enzymes of the PI4P metabolism and auxiliary proteins to determine the lipid composition of the Golgi apparatus. This is critical for the formation of transport vesicles that carry proteins from the Golgi to the PM [52] and has an impact on the inner organization of the PM [53].

Finally, as suggested by these data, a reason why LTPs are secluded in contact sites is probably to combine their activities with those of local protein partners, and thereby perform specialized cellular functions. Recent studies have confirmed this notion, showing that diverse ORP/Osh proteins exchange lipids at contact sites to support specific vesicular trafficking routes. In yeast, Osh2 functions as a sterol/PI4P exchanger in ER-PM contacts, where it associates with Myo5, a protein required for actin polymerization and scission of endocytic vesicles (Figure 3b) [54]. Myo5 also interacts with ER-resident proteins involved in ergosterol biosynthesis [55]. Presumably, all these proteins co-operate to channel ergosterol to the PM and create sterol-rich membrane domains where actin polymerization is facilitated to promote endocytosis [55]. In contrast, it is likely that Osh1, which occupies ER-Golgi contacts, performs sterol/PI4P exchange to regulate post-Golgi vesicular trafficking [56]. In human cells, ORP10 exchanges PS for PI4P in ER-endosome contacts to deliver PS to the endosomal membrane (Figure 3c). This promotes the recruitment of the EHD1 protein whose membrane scission activity triggers the formation of tubulovesicular carriers that recycle proteins from the endosomes to the Golgi [57].

Massive lipid transfer or fine-tuning of local lipid content?

If today we are aware of the existence of protein networks that ensure one-way lipid transfers, it remains difficult to quantify how much they contribute to the impressive asymmetries in lipid distribution observed in the cell. First, although many approaches have been developed to map cellular lipid routes, for instance by using fluorescent lipids [58], lipid labelling procedures [58] or genetically encoded lipid sensors [58,59], these methods are not entirely suitable for precisely quantifying lipid fluxes. Second, *in vitro* assays provide key insights into the function of LTPs, but they are not realistic enough to define the exact speed at which these proteins carry lipids in the complex environment of the cell [60].

Attempts have been made to estimate how much lipid is transferred by given LTPs in cells considering their abundance and the speed at which they transfer their lipid ligands *in vitro* [25,60]. Calculations have also been made in specific cases in which the cellular abundance and contribution of LTPs to the synthesis of particular lipid species via the transport of their precursor were known [60]. Regarding ORP/Osh activity, insights came from the analysis of cellular PI4P levels. This lipid is present in minute amounts in the cell (in yeast, only 0.2% of lipids [61]) compared with sterol and PS, which seems incompatible with ORP/Osh-mediated exchange processes. Yet, in yeast lacking Sac1 or all Osh proteins, PI4P levels can be multiplied by up to ~20 [62,63]. This suggests that substantial quantities of PI4P are constantly produced and consumed by networks involving Sac1 and ORP/Osh proteins to move lipids. In parallel, Osh6 and Osh7 were found to be responsible for 30% of PS delivery to the PM [29]. Later, investigations revealed that OSBP uses half of PI4P synthesized in a human cell to mediate 30–60% of ER-to-Golgi sterol transfer [27]. Thus ORP/Osh proteins seem able to transfer significant amount of lipids for creating lipid asymmetries.

However, in different cases, the *raison d'être* of ORP/Osh proteins is perhaps not to use the PI4P metabolism to deliver massive quantities of lipids to cellular membranes. Osh4 served as a great prototypical case to uncover PI4P-driven lipid exchange, but paradoxically there is no direct evidence besides a few clues that it delivers sterol in the Golgi in yeast cells [5,64]. Instead, it seems more certain that its role is to lower PI4P levels in post-Golgi secretory vesicles for functional purposes [65,66]. Also, OSBP was found to localize at ER-endosome contacts to control protein recycling not by delivering sterol but by adjusting the level of a small pool of endosomal PI4P [67]. Possibly, these proteins perform limited sterol/PI4P exchange to regulate the
<figure><img src="image_13.png" /></figure>

PI4P level of given membranes or control their sterol/PI4P balance. Another idea is that a LTP like Osh4 acts as a negative regulator of PI4P signalling by sequestering this lipid, and that a high concentration of sterol lifts its inhibitory action [68].

Moreover, studies of ORP5 and ORP8 in humans have shown that besides supplying the PM with PS, they also regulate the level of the main signalling lipid present in this membrane, which is PIP~2~. These proteins are ER-anchored [69,70] and associate with the PM if the latter contains threshold PI4P and PIP~2~ amounts, to join ER-PM contacts [31,71,72]. The PM is then enriched in PS but its content in PIP~2~ decreases [71,72]. This is because PI4P, which is used as fuel for PS/PI4P exchange also serves as substrate for PIP~2~ synthesis (it is unlikely that PS and PIP~2~ are directly exchanged [41,72]). When PI4P and PIP~2~ levels become too low, the proteins exit contact sites, PS transfer stops, and proper phosphoinositide levels are restored. So, ORP5 and ORP8 seem to constitute the molecular basis of a complex mechanism whose function is more to finely adjust the lipid composition of the PM, and thereby the signalling capacity of the cells [72], than to massively import PS in the PM (Figure 4). Side mechanisms are thought to regulate PS and PI4P flows. For instance, PS inhibits its own synthesis in the ER and this strongly influences PS/PI4P exchange [73]. Sac1 can be activated by PS [74], suggesting that an elevation of PS in the ER could generate a steeper PI4P gradient to sustain lipid exchange. PS might also promote the conversion of PI4P into PIP~2~ by PI4P 5-kinase in the PM [75]. It is increasingly appreciated that dysregulation of this complex protein network can impact the recruitment of oncogenic proteins (e.g. KRAS) at the PM, and be associated with cancers [76].

## Sensing lipid asymmetry to rectify cellular lipid levels

Some networks involving LTPs are clearly tailored not to create lipid asymmetries but to sense a change in asymmetry and subsequently rectify the cellular level of particular lipids. One of these is critical to guarantee the signalling competence of the cell. In many signalling pathways, the activation of cell surface receptors triggers the hydrolysis of PIP~2~ by phospholipase, which generates DAG and IP~3~ as second messengers. PIP~2~ levels must subsequently be restored so that the cells can respond once again to stimulation. This requires several enzymatic steps that constitute the PI cycle [77]. First, DAG is converted into phosphatidic acid (PA) in the PM. Next, PA is converted into PI in the ER membrane. Finally, in the PM, PI undergoes two successive phosphorylations leading to PIP~2~ re-synthesis (Figure 5a). As hypothesized as early as 1975, the PI cycle can function only if PA and PI are exchanged between the ER and the PM to guarantee lipid flows between the spatially distant enzymes of this cycle [78]. As described below, long-term efforts have led to the identification of LTPs — Nir2 and Nir3 in humans — as the missing pieces of the puzzle,

<figure><img src="image_14.png" /><figcaption>Figure 4. A rheostat mechanism to control PS, PI4P and PIP~2~ levels in the plasma membrane.</figcaption></figure>

ORP5 and ORP8 are anchored to the ER by a transmembrane domain (TMD) and associate with the PM by interacting with PI4P and/or PIP~2~ via their PH domain to join ER-PM contacts. When the PIP~2~ levels are high, ORP8 is recruited together with ORP5, and both proteins supply PS while decreasing the PI4P level, which limits PIP~2~ synthesis. At a low PIP~2~ level, only ORP5 docks and supplies PS to the PM unless the PI4P pool is exhausted. When there is not enough PI4P and PIP~2~, ORP5 and ORP8 disengage from contact sites. PSS1 synthesizes PS and its activity is inhibited by the end-product of the reaction. PS likely activates Sac1 in the ER and promotes the synthesis of PIP~2~ in the PM. This complex protein network determines the lipid content of the PM, which impacts the recruitment of the oncogenic protein KRAS by electrostatic interaction.
<figure><img src="image_15.png" /><figcaption>**Figure 5.** Sensing and exploiting a change in lipid asymmetry to rectify cellular lipid content.</figcaption></figure>

(a) Nir2 is associated with the ER-resident VAP receptor via its FFAT motif (step 1). Following the accumulation of DAG and PA resulting from the hydrolysis of PIP₂, Nir2 engages the PM via its PA-binding domain LNS2 (Lipin/Nde1/Smp2) and DAG-binding-like domain (DGBL). PI is already present in the ER; thus the presence of PA in the PM creates the conditions for immediate PA/PI exchange as PI and PA are concentrated in distinct membranes. PA and PI could thus be rapidly exchanged by the PITD domain of Nir2, which can host the two lipids in a mutually exclusive manner. The conversion of PA into PI likely sustains this exchange until the full clearance of PA from the PM and the replenishment of PIP₂ levels (step 2). Then Nir2 disengages from ER-PM contacts (step 3). PLC: phospholipase, DAGK: DAG kinase; CDS: CDP-DAG synthase, PIS: PI synthase; PI4K: PI 4-kinase; PIP5K: PI4P 5-kinase. (b) Aster proteins are anchored to the ER membrane and form dimeric complexes (step 1). Following a transient expansion of the accessible pool of sterol in the PM, they localize to ER-PM contacts, by detecting the concomitant presence of cholesterol and PS in the inner leaflet of the PM (step 2). Cholesterol is then transferred by the START-like domain of Aster, down its concentration gradient, to the ER, where it is esterified and stored in lipid droplets. The increase in the ER cholesterol level also leads to the down-regulation at the transcriptional level, of sterol synthesis and uptake via the SREBP2 pathway (involving Insig/SCAP/SREBP proteins). When sterol levels are rectified, Aster proteins exit ER-PM contacts (step 3). In theory, an increase in the sterol level of the inner leaflet of the PM, caused by a mixing of lipids (scrambling) of the two membrane leaflets, is unlikely to trigger the recruitment of Aster. Indeed, PS, which is mostly present in the inner leaflet would be simultaneously diluted across the membrane. CLR: cholesterol; CLR-est: Cholesteryl ester; ACAT: Acyl-CoA cholesterol acyltransferase.

These proteins are attached to the ER [79] and have a domain to alternatively capture PA and PI [80]. In addition, they possess a PA-binding domain and likely a DAG-binding domain to associate with the PM [81,82]. Recent data suggest the following scenario. The generation of DAG and PA triggers the translocation of Nir proteins to ER-PM contacts [82]. The accumulation of PA in the PM creates an asymmetry in PA at
<figure><img src="image_16.png" /></figure>

ER-PM contacts. Because PI is absent from the PM and already abundant in the ER [83,84], this likely sets the conditions for immediate PA/PI exchange as PA and PI are concentrated in distinct membranes. Next, PA is converted into PI in the ER, which sustains the exchange process until a full clearance of PA [82] and replenishment of the PIP₂ stock. Finally, as PA is cleared from the PM, Nir proteins disengage from contact sites. Interestingly, compared with Nir2, Nir3 has a weaker PA-transfer capacity but a higher capacity to detect small amounts of PA in the PM [85]. Consequently, Nir3 adjusts the PIP₂ level in resting cells, whereas Nir2 is only mobilized during acute receptor activation.

A second example was provided by the characterization of a newly discovered family of LTPs (Asters in humans, Lam/Ltc in yeast). These are ER-anchored proteins that have a PH-like domain called GRAM to associate with a second organelle and a sterol-transfer module [86,87]. Studies have shown that these proteins occupy contact sites between the ER and the mitochondrion, vacuole or PM to potentially serve as sterol transporters [86,87]. Remarkably, the GRAM domain of Asters (also called GRAMD1) has two binding sites for recognizing cholesterol and PS in a synergistic manner [88–90]. Consequently, in human cells, Asters can specifically join ER-PM contacts by sensing in the PM, in which PS is present, the transient expansion of an accessible pool of cholesterol resulting from the uptake of sterol by endocytosis of low-density or high-density lipoproteins [88,90–92]. Next, Asters transfer cholesterol down its concentration gradient to the ER; cholesterol is subsequently esterified to be stored in lipid droplets [91,92] (Figure 5b). Additionally, the sterol level increase in the ER down-regulates via the SREBP2 pathways the transcription of gene coding for the synthesis of cholesterol and its uptake [88,89,91,92]. Remarkably, Asters use their transfer activity to act as messengers. They inform the regulatory mechanisms that control the biosynthesis and uptake of sterol, present in the ER, of the overabundance of cholesterol in the PM, preventing the toxic accumulation of this lipid in the cell. This has important implications, since defects in this mechanism can result in a lack of steroid hormone synthesis in model animals [91] and might be linked to intellectual disability in humans [89].

## Conclusion and perspectives

LTPs assisted by lipid-synthesizing enzymes vectorially transfer lipids between organelles. It is critical to better quantify whether this serves to create lipid asymmetries throughout the cell and/or to fine-tune the lipid content of organelles. More work is also required to better define which lipid ligands are recognized by different LTPs and/or whether these LTPs function as lipid exchangers or mere lipid transporters. In some cases, the mechanism by which an LTP accumulates lipids in organelles remains particularly elusive [93]. In parallel, significant efforts are being undertaken to dissect networks present at ER-mitochondrion contacts and inside the mitochondria that contribute to the generation of key cellular lipids, among which specific mitochondrial ones [94]. The recent discovery of diverse LTPs at the mitochondrial surface raises exciting questions [95,96]. Finally, some evidence suggests that vesicular trafficking also contributes to creating lipid asymmetry via lipid sorting mechanisms whose characteristics remain to be defined [5,97,98]. In the future, a better understanding of how asymmetries in lipid distribution are created should provide key outcomes in basic cell biology and answer health-related questions.

## Summary

* LTPs assisted by lipid-synthesizing enzymes can move lipids in a directional manner between two cellular membranes.

* Lipid transfers mostly occur in contact sites where membranes are extremely close for several functional purposes.

* These transfer processes contribute to creating asymmetric lipid distributions in the cell and/or fine-tuning the lipid composition of cellular membranes.

* Some LTPs play a key role in mechanisms that rectify the cellular level of particular lipids following changes in lipid asymmetry.
**Competing Interests**

The author declares that there are no competing interests associated with this manuscript.

**Funding**

This work was supported by the Agence Nationale de la Recherche (ANR-20-CE13-0030-02 grant) and the CNRS.

**Author Contribution**

G.D. conceptualized and wrote the manuscript.

**Acknowledgements**

I am grateful to Ms. Y. Van Der Does for her careful corrections and proofreading of the manuscript.

**Abbreviations**

CERT, ceramide transfer protein; DAG, diacylglycerol; ER, endoplasmic reticulum; LTP, lipid transfer protein; ORD, OSBP-related domain; ORP, oxysterol-binding protein related-proteins; Osh, oxysterol-binding homology; PA, phosphatidic acid; PH, Pleckstrin Homology; PI, phosphatidylinositol; PI4P, phosphatidylinositol 4-phosphate; PIP₂, phosphatidylinositol 4,5-bisphosphate; PM, plasma membrane.

**References**

1. Holthuis, J.C. and Menon, A.K. (2014) Lipid landscapes and pipelines in membrane homeostasis. *Nature* **510**, 48–57 https://doi.org/10.1038/nature13474

2. Bigay, J. and Antonny, B. (2012) Curvature, lipid packing, and electrostatics of membrane organelles: defining cellular territories in determining specificity. *Dev. Cell* **23**, 886–895 https://doi.org/10.1016/j.devcel.2012.10.009

3. Ejsing, C.S., Sampaio, J.L., Surendranath, V., Duchoslav, E., Ekroos, K., Klemm, R.W. et al. (2009) Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry. *Proc. Natl Acad. Sci. U.S.A.* **106**, 2136–2141 https://doi.org/10.1073/pnas.0811700106

4. Sampaio, J.L., Gerl, M.J., Klose, C., Ejsing, C.S., Beug, H., Simons, K. et al. (2011) Membrane lipidome of an epithelial cell line. *Proc. Natl Acad. Sci. U.S.A.* **108**, 1903–1907 https://doi.org/10.1073/pnas.1019267108

5. Klemm, R.W., Ejsing, C.S., Surma, M.A., Kaiser, H.J., Gerl, M.J., Sampaio, J.L. et al. (2009) Segregation of sphingolipids and sterols during formation of secretory vesicles at the trans-Golgi network. *J. Cell Biol.* **185**, 601–612 https://doi.org/10.1083/jcb.200901145

6. Zinser, E., Sperka-Gottlieb, C.D., Fasch, E.V., Kohlwein, S.D., Paltauf, F. and Daum, G. (1991) Phospholipid synthesis and lipid composition of subcellular membranes in the unicellular eukaryote *Saccharomyces cerevisiae*. *J. Bacteriol.* **173**, 2026–2034 https://doi.org/10.1128/jb.173.6.2026-2034.1991

7. Schneiter, R., Brugger, B., Sandhoff, R., Zellnig, G., Leber, A., Lampl, M. et al. (1999) Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species en route to the plasma membrane. *J. Cell Biol.* **146**, 741–754 https://doi.org/10.1083/jcb.146.4.741

8. Andreyev, A.Y., Fahy, E., Guan, Z., Kelly, S., Li, X., McDonald, J.G. et al. (2010) Subcellular organelle lipidomics in TLR-4-activated macrophages. *J. Lipid Res.* **51**, 2785–2797 https://doi.org/10.1194/jlr.M008748

9. Mesmin, B. and Maxfield, F.R. (2009) Intracellular sterol dynamics. *Biochim. Biophys. Acta* **1791**, 636–645 https://doi.org/10.1016/j.bbalip.2009.03.002

10. Levental, I., Levental, K.R. and Heberle, F.A. (2020) Lipid rafts: controversies resolved, mysteries remain. *Trends Cell Biol.* **30**, 341–353 https://doi.org/10.1016/j.tcb.2020.01.009

11. Daum, G., Tuller, G., Nemec, T., Hrastnik, C., Balliano, G., Cattel, L. et al. (1999) Systematic analysis of yeast strains with possible defects in lipid metabolism. *Yeast* **15**, 601–614 https://doi.org/10.1002/(SICI)1097-0061(199905)15:7&lt;601::AID-YEA390&gt;3.0.CO;2-N

12. Vance, J.E. and Steenbergen, R. (2005) Metabolism and functions of phosphatidylserine. *Prog. Lipid Res.* **44**, 207–234 https://doi.org/10.1016/j.plipres.2005.05.001

13. Leventis, P.A. and Grinstein, S. (2010) The distribution and function of phosphatidylserine in cellular membranes. *Annu. Rev. Biophys.* **39**, 407–427 https://doi.org/10.1146/annurev.biophys.093008.131234

14. Kay, J.G. and Fairn, G.D. (2019) Distribution, dynamics and functional roles of phosphatidylserine within the cell. *Cell Commun. Signal.* **17**, 126 https://doi.org/10.1186/s12964-019-0438-z

15. Lenoir, G., D'Ambrosio, J.M., Dieudonne, T. and Copic, A. (2021) Transport pathways that contribute to the cellular distribution of phosphatidylserine. *Front. Cell Dev. Biol.* **9**, 737907 https://doi.org/10.3389/fcell.2021.737907

16. Posor, Y., Jang, W. and Haucke, V. (2022) Phosphoinositides as membrane organizers. *Nat. Rev. Mol. Cell Biol.* https://doi.org/10.1038/s41580-022-00490-x

17. Dickson, E.J. and Hille, B. (2019) Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids. *Biochem. J.* **476**, 1–23 https://doi.org/10.1042/BCJ20180022

18. Wong, L.H., Gatta, A.T. and Levine, T.P. (2019) Lipid transfer proteins: the lipid commute via shuttles, bridges and tubes. *Nat. Rev. Mol. Cell Biol.* **20**, 85–101 https://doi.org/10.1038/s41580-018-0071-5

19. Egea, P.F. (2021) Mechanisms of non-vesicular exchange of lipids at membrane contact sites: of shuttles, tunnels and, funnels. *Front. Cell Dev. Biol.* **9**, 784367 https://doi.org/10.3389/fcell.2021.784367
<figure><img src="image_17.png" /></figure>

20 Scorrano, L., De Matteis, M.A., Emr, S., Giordano, F., Hajnoczky, G., Kornmann, B. et al. (2019) Coming together to define membrane contact sites. *Nat. Commun.* **10**, 1287 https://doi.org/10.1038/s41467-019-09253-3

21 Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M. et al. (2003) Molecular machinery for non-vesicular trafficking of ceramide. *Nature* **426**, 803–809 https://doi.org/10.1038/nature02188

22 Delfosse, V., Bourguet, W. and Drin, G. (2020) Structural and functional specialization of OSBP-related proteins. *Contact* **3**, 2515256420946627 https://doi.org/10.1177/2515256420946627

23 Im, Y.J., Raychaudhuri, S., Prinz, W.A. and Hurley, J.H. (2005) Structural mechanism for sterol sensing and transport by OSBP-related proteins. *Nature* **437**, 154–158 https://doi.org/10.1038/nature03923

24 de Saint-Jean, M., Delfosse, V., Douguet, D., Chicanne, G., Payrastre, B., Bourguet, W. et al. (2011) Osh4p exchanges sterols for phosphatidylinositol 4-phosphate between lipid bilayers. *J. Cell Biol.* **195**, 965–978 https://doi.org/10.1083/jcb.201104062

25 Moser von Filseck, J., Vanni, S., Mesmin, B., Antonny, B. and Drin, G. (2015) A phosphatidylinositol-4-phosphate powered exchange mechanism to create a lipid gradient between membranes. *Nat. Commun.* **6**, 6671 https://doi.org/10.1038/ncomms7671

26 Mesmin, B., Bigay, J., von Filseck J, M., Lacas-Gervais, S., Drin, G. and Antonny, B. (2013) A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP. *Cell* **155**, 830–843 https://doi.org/10.1016/j.cell.2013.09.056

27 Mesmin, B., Bigay, J., Polidori, J., Jamecna, D., Lacas-Gervais, S. and Antonny, B. (2017) Sterol transfer, PI4P consumption, and control of membrane lipid order by endogenous OSBP. *EMBO J.* **36**, 3156–3174 https://doi.org/10.15252/embj.201796687

28 Zewe, J.P., Wills, R.C., Sangappa, S., Goulden, B.D. and Hammond, G.R. (2018) SAC1 degrades its lipid substrate PtdIns4P in the endoplasmic reticulum to maintain a steep chemical gradient with donor membranes. *eLife* **7**, e35588 https://doi.org/10.7554/eLife.35588

29 Maeda, K., Anand, K., Chiapparino, A., Kumar, A., Poletto, M., Kaksonen, M. et al. (2013) Interactome map uncovers phosphatidylserine transport by oxysterol-binding proteins. *Nature* **501**, 257–261 https://doi.org/10.1038/nature12430

30 Moser von Filseck, J., Copic, A., Delfosse, V., Vanni, S., Jackson, C.L., Bourguet, W. et al. (2015) INTRACELLULAR TRANSPORT. Phosphatidylserine transport by ORP/Osh proteins is driven by phosphatidylinositol 4-phosphate. *Science* **349**, 432–436 https://doi.org/10.1126/science.aab1346

31 Chung, J., Torta, F., Masai, K., Lucast, L., Czapla, H., Tanner, L.B. et al. (2015) INTRACELLULAR TRANSPORT. PI4P/phosphatidylserine countertransport at ORP5- and ORP8-mediated ER-plasma membrane contacts. *Science* **349**, 428–432 https://doi.org/10.1126/science.aab1370

32 Moser von Filseck, J. and Drin, G. (2016) Running up that hill: how to create cellular lipid gradients by lipid counter-flows. *Biochimie* **130**, 115–121 https://doi.org/10.1016/j.biochi.2016.08.001

33 West, M., Zurek, N., Hoenger, A. and Voeltz, G.K. (2011) A 3D analysis of yeast ER structure reveals how ER domains are organized by membrane curvature. *J. Cell Biol.* **193**, 333–346 https://doi.org/10.1083/jcb.201011039

34 Thomas, P.D. and Poznansky, M.J. (1988) Effect of surface curvature on the rate of cholesterol transfer between lipid vesicles. *Biochem. J.* **254**, 155–160 https://doi.org/10.1042/bj2540155

35 Sugiura, T., Nakao, H., Ikeda, K., Khan, D., Nile, A.H., Bankaitis, V.A. et al. (2021) Biophysical parameters of the Sec14 phospholipid exchange cycle - effect of lipid packing in membranes. *Biochim. Biophys. Acta Biomembr.* **1863**, 183450 https://doi.org/10.1016/j.bbamem.2020.183450

36 Hoffmann, P.C., Bharat, T.A.M., Wozny, M.R., Boulanger, J., Miller, E.A. and Kukulski, W. (2019) Tricalbins contribute to cellular lipid flux and form curved ER-PM contacts that are bridged by rod-shaped structures. *Dev. Cell* **51**, 488–502.e8 https://doi.org/10.1016/j.devcel.2019.09.019

37 Collado, J., Kalemanov, M., Campelo, F., Bourgoint, C., Thomas, F., Loewith, R. et al. (2019) Tricalbin-mediated contact sites control ER curvature to maintain plasma membrane integrity. *Dev. Cell* **51**, 476–487.e7 https://doi.org/10.1016/j.devcel.2019.10.018

38 Baumann, N.A., Sullivan, D.P., Ohvo-Rekila, H., Simonot, C., Pottekat, A., Klaassen, Z. et al. (2005) Transport of newly synthesized sterol to the sterol-enriched plasma membrane occurs via nonvesicular equilibration. *Biochemistry* **44**, 5816–5826 https://doi.org/10.1021/bi048296z

39 Hirama, T., Lu, S.M., Kay, J.G., Maekawa, M., Kozlov, M.M., Grinstein, S. et al. (2017) Membrane curvature induced by proximity of anionic phospholipids can initiate endocytosis. *Nat. Commun.* **8**, 1393 https://doi.org/10.1038/s41467-017-01554-9

40 Maekawa, M. and Fairn, G.D. (2015) Complementary probes reveal that phosphatidylserine is required for the proper transbilayer distribution of cholesterol. *J. Cell Sci.* **128**, 1422 https://doi.org/10.1242/jcs.164715

41 Ikhlef, S., Lipp, N.-F., Delfosse, V., Fuggetta, N., Bourguet, W., Magdeleine, M. et al. (2021) Functional analyses of phosphatidylserine/PI(4)P exchangers with diverse lipid species and membrane contexts reveal unanticipated rules on lipid transfer. *BMC Biol.* **19**, 248 https://doi.org/10.1186/s12915-021-01183-1

42 Dittman, J.S. and Menon, A.K. (2017) Speed limits for nonvesicular intracellular sterol transport. *Trends Biochem. Sci.* **42**, 90–97 https://doi.org/10.1016/j.tibs.2016.11.004

43 Loewen, C.J., Roy, A. and Levine, T.P. (2003) A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP. *EMBO J.* **22**, 2025–2035 https://doi.org/10.1093/emboj/cdg201

44 Levine, T.P. and Munro, S. (2002) Targeting of Golgi-specific pleckstrin homology domains involves both PtdIns 4-kinase-dependent and -independent components. *Curr. Biol.* **12**, 695–704 https://doi.org/S0960982202007790

45 Capasso, S., Sticco, L., Rizzo, R., Pirozzi, M., Russo, D., Dathan, N.A. et al. (2017) Sphingolipid metabolic flow controls phosphoinositide turnover at the trans-Golgi network. *EMBO J.* **36**, 1736–1754 https://doi.org/10.15252/embj.201696048

46 Prashek, J., Bouyain, S., Fu, M., Li, Y., Berkes, D. and Yao, X. (2017) Interaction between the PH and START domains of ceramide transfer protein competes with phosphatidylinositol 4-phosphate binding by the PH domain. *J. Biol. Chem.* **292**, 14217–14228 https://doi.org/10.1074/jbc.M117.780007

47 Sugiki, T., Egawa, D., Kumagai, K., Kojima, C., Fujiwara, T., Takeuchi, K. et al. (2018) Phosphoinositide binding by the PH domain in ceramide transfer protein (CERT) is inhibited by hyperphosphorylation of an adjacent serine-repeat motif. *J. Biol. Chem.* **293**, 11206–11217 https://doi.org/10.1074/jbc.RA118.002465

48 Hausser, A., Storz, P., Martens, S., Link, G., Toker, A. and Pfizenmaier, K. (2005) Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex. *Nat. Cell Biol.* **7**, 880–886 https://doi.org/10.1038/ncb1289

49 Nhek, S., Ngo, M., Yang, X., Ng, M.M., Field, S.J., Asara, J.M. et al. (2010) Regulation of oxysterol-binding protein Golgi localization through protein kinase D-mediated phosphorylation. *Mol. Biol. Cell* **21**, 2327–2337 https://doi.org/10.1091/mbc.E10-02-0090
50 Fugmann, T., Hausser, A., Schoffler, P., Schmid, S., Pfizenmaier, K. and Olayioye, M.A. (2007) Regulation of secretory transport by protein kinase D-mediated phosphorylation of the ceramide transfer protein. *J. Cell Biol.* **178**, 15–22 https://doi.org/10.1083/jcb.200612017

51 Lu, D., Sun, H.Q., Wang, H., Barylko, B., Fukata, Y., Fukata, M. et al. (2012) Phosphatidylinositol 4-kinase Ilalpha is palmitoylated at Golgi-localized palmitoyltransferases in cholesterol-dependent manner. *J. Biol. Chem.* **287**, 21856–21865 https://doi.org/10.1074/jbc.M112.348094

52 Wakana, Y., Kotake, R., Oyama, N., Murate, M., Kobayashi, T., Arasaki, K. et al. (2015) CARTS biogenesis requires VAP-lipid transfer protein complexes functioning at the endoplasmic reticulum-Golgi interface. *Mol. Biol. Cell* **26**, 4686–4699 https://doi.org/10.1091/mbc.E15-08-0599

53 Malek, M., Wawrzyniak, A.M., Koch, P., Luchtenborg, C., Hessenberger, M., Sachsenheimer, T. et al. (2021) Inositol triphosphate-triggered calcium release blocks lipid exchange at endoplasmic reticulum-Golgi contact sites. *Nat. Commun.* **12**, 2673 https://doi.org/10.1038/s41467-021-22882-x

54 Encinar del Dedo, J., Idrissi, F.Z., Fernandez-Golbano, I.M., Garcia, P., Rebollo, E., Krzyzanowski, M.K. et al. (2017) ORP-mediated ER contact with endocytic sites facilitates actin polymerization. *Dev. Cell* **43**, 588–602.e6 https://doi.org/10.1016/j.devcel.2017.10.031

55 Encinar del Dedo, J., Fernandez-Golbano, I.M., Pastor, L., Meler, P., Ferrer-Orta, C., Rebollo, E. et al. (2021) Coupled sterol synthesis and transport machineries at ER-endocytic contact sites. *J. Cell Biol.* **220**, e202010016 https://doi.org/10.1083/jcb.202010016

56 Shin, J.J.H., Liu, P., Chan, L.J., Ullah, A., Pan, J., Borchers, C.H. et al. (2020) Ph biosensing by PI4P regulates cargo sorting at the TGN. *Dev. Cell* **52**, 461–476.e4 https://doi.org/10.1016/j.devcel.2019.12.010

57 Kawasaki, A., Sakai, A., Nakanishi, H., Hasegawa, J., Taguchi, T., Sasaki, J. et al. (2022) PI4P/PS countertransport by ORP10 at ER-endosome membrane contact sites regulates endosome fission. *J. Cell Biol.* **221**, e202103141 https://doi.org/10.1083/jcb.202103141

58 Schoop, V., Martello, A., Eden, E.R. and Hoglinger, D. (2021) Cellular cholesterol and how to find it. *Biochim. Biophys. Acta Mol. Cell. Biol. Lipids* **1866**, 158989 https://doi.org/10.1016/j.bbalip.2021.158989

59 Hammond, G.R.V., Ricci, M.M.C., Weckerly, C.C. and Wills, R.C. (2022) An update on genetically encoded lipid biosensors. *Mol. Biol. Cell* **33**, tp2 https://doi.org/10.1091/mbc.E21-07-0363

60 Wong, L.H., Copic, A. and Levine, T.P. (2017) Advances on the transfer of lipids by lipid transfer proteins. *Trends Biochem. Sci.* **42**, 516–530 https://doi.org/10.1016/j.tibs.2017.05.001

61 Audhya, A., Foti, M. and Emr, S.D. (2000) Distinct roles for the yeast phosphatidylinositol 4-kinases, Stt4p and Pik1p, in secretion, cell growth, and organelle membrane dynamics. *Mol. Biol. Cell* **11**, 2673–2689 https://doi.org/10.1091/mbc.11.8.2673

62 Foti, M., Audhya, A. and Emr, S.D. (2001) Sac1 lipid phosphatase and Stt4 phosphatidylinositol 4-kinase regulate a pool of phosphatidylinositol 4-phosphate that functions in the control of the actin cytoskeleton and vacuole morphology. *Mol. Biol. Cell* **12**, 2396–2411 https://doi.org/10.1091/mbc.12.8.2396

63 Stefan, C.J., Manford, A.G., Baird, D., Yamada-Hanff, J., Mao, Y. and Emr, S.D. (2011) Osh proteins regulate phosphoinositide metabolism at ER-plasma membrane contact sites. *Cell* **144**, 389–401 https://doi.org/10.1016/j.cell.2010.12.034

64 Fairin, G.D., Curwin, A.J., Stefan, C.J. and McMaster, C.R. (2007) The oxysterol binding protein Kes1p regulates Golgi apparatus phosphatidylinositol-4-phosphate function. *Proc. Natl Acad. Sci. U.S.A.* **104**, 15352–15357 https://doi.org/10.1073/pnas.0705571104

65 Smindak, R.J., Heckle, L.A., Chittari, S.S., Hand, M.A., Hyatt, D.M., Mantus, G.E. et al. (2017) Lipid-dependent regulation of exocytosis in *S. cerevisiae* by OSBP homolog (Osh) 4. *J. Cell Sci.* **130**, 3891–3906 https://doi.org/10.1242/jcs.205435

66 Ling, Y., Hayano, S. and Novick, P. (2014) Osh4p is needed to reduce the level of phosphatidylinositol-4-phosphate on secretory vesicles as they mature. *Mol. Biol. Cell* **25**, 3389–3400 https://doi.org/10.1091/mbc.E14-06-1087

67 Dong, R., Saheki, Y., Swarup, S., Lucast, L., Harper, J.W. and De Camilli, P. (2016) Endosome-ER contacts control actin nucleation and retromer function through VAP-dependent regulation of PI4P. *Cell* **166**, 408–423 https://doi.org/10.1016/j.cell.2016.06.037

68 Wang, Y., Mousley, C.J., Lete, M.G. and Bankaitis, V.A. (2019) An equal opportunity collaboration between lipid metabolism and proteins in the control of membrane trafficking in the trans-Golgi and endosomal systems. *Curr. Opin. Cell Biol.* **59**, 58–72 https://doi.org/10.1016/j.ceb.2019.03.012

69 Yan, D., Mayranpaa, M.I., Wong, J., Perttila, J., Lehto, M., Jauhiainen, M. et al. (2008) OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages. *J. Biol. Chem.* **283**, 332–340 https://doi.org/10.1074/jbc.M705313200

70 Du, X., Kumar, J., Ferguson, C., Schulz, T.A., Ong, Y.S., Hong, W. et al. (2012) A role for oxysterol-binding protein-related protein 5 in endosomal cholesterol trafficking. *J. Cell Biol.* **192**, 121–135 https://doi.org/10.1083/jcb.201004142

71 Ghai, R., Du, X., Wang, H., Dong, J., Ferguson, C., Brown, A.J. et al. (2017) ORP5 and ORP8 bind phosphatidylinositol-4, 5-biphosphate (PtdIns(4,5)P2) and regulate its level at the plasma membrane. *Nat. Commun.* **8**, 757 https://doi.org/10.1038/s41467-017-00861-5

72 Sohn, M., Korzeniowski, M., Zewe, J.P., Wills, R.C., Hammond, G.R.V., Humpolickova, J. et al. (2018) PI(4,5)P2 controls plasma membrane PI4P and PS levels via ORP5/8 recruitment to ER-PM contact sites. *J. Cell Biol.* **217**, 1797–1813 https://doi.org/10.1083/jcb.201710095

73 Sohn, M., Ivanova, P., Brown, H.A., Toth, D.J., Varnai, P., Kim, Y.J. et al. (2016) Lenz-Majewski mutations in PTDS1 affect phosphatidylinositol 4-phosphate metabolism at ER-PM and ER-Golgi junctions. *Proc. Natl Acad. Sci. U.S.A.* **113**, 4314–4319 https://doi.org/10.1073/pnas.1525719113

74 Zhong, S., Hsu, F., Stefan, C.J., Wu, X., Patel, A., Cosgrove, M.S. et al. (2012) Allosteric activation of the phosphoinositide phosphatase Sac1 by anionic phospholipids. *Biochemistry* **51**, 3170–3177 https://doi.org/10.1021/bi300086c

75 Nishimura, T., Gecht, M., Covino, R., Hummer, G., Surma, M.A., Klose, C. et al. (2019) Osh proteins control nanoscale lipid organization necessary for PI(4,5)P2 synthesis. *Mol. Cell* **75**, 1043–1057.e8 https://doi.org/10.1016/j.molcel.2019.06.037

76 Kattan, W.E., Liu, J., Montufar-Solis, D., Liang, H., Brahmendra Barathi, B., van der Hoeven, R. et al. (2021) Components of the phosphatidylyserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer. *Proc. Natl Acad. Sci. U.S.A.* **118**, e2114126118 https://doi.org/10.1073/pnas.2114126118

77 Epand, R.M. (2017) Features of the phosphatidylinositol cycle and its role in signal transduction. *J. Membr. Biol.* **250**, 353–366 https://doi.org/10.1007/s00232-016-9909-y

78 Michell, R.H. (1975) Inositol phospholipids and cell surface receptor function. *Biochim. Biophys. Acta* **415**, 81–47 https://doi.org/10.1016/0304-4157(75)90017-9

79 Amarilio, R., Ramachandran, S., Sabanay, H. and Lev, S. (2005) Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. *J. Biol. Chem.* **280**, 5934–5944 https://doi.org/10.1074/jbc.M409566200

80 Garner, K., Hunt, A.N., Koster, G., Somerharju, P., Groves, E., Li, M. et al. (2012) Phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1) binds and transfers phosphatidic acid. *J. Biol. Chem.* **287**, 32263–32276 https://doi.org/10.1074/jbc.M112.375840
<figure><img src="image_18.png" /></figure>

81 Kim, S., Kedan, A., Marom, M., Gavert, N., Keinan, O., Selitrennik, M. et al. (2013) The phosphatidylinositol-transfer protein Nir2 binds phosphatidic acid and positively regulates phosphoinositide signalling. *EMBO Rep.* **14**, 891–899 https://doi.org/10.1038/embor.2013.113

82 Kim, Y.J., Guzman-Hernandez, M.L., Wisniewski, E. and Balla, T. (2015) Phosphatidylinositol-Phosphatidic acid exchange by Nir2 at ER-PM contact sites maintains phosphoinositide signaling competence. *Dev. Cell* **33**, 549–561 https://doi.org/10.1016/j.devcel.2015.04.028

83 Pemberton, J.G., Kim, Y.J., Humpolickova, J., Eisenreichova, A., Sengupta, N., Toth, D.J. et al. (2020) Defining the subcellular distribution and metabolic channeling of phosphatidylinositol. *J. Cell Biol.* **219** (3) https://doi.org/10.1083/jcb.201906130

84 Zewe, J.P., Miller, A.M., Sangappa, S., Wills, R.C., Goulden, B.D. and Hammond, G.R.V. (2020) Probing the subcellular distribution of phosphatidylinositol reveals a surprising lack at the plasma membrane. *J. Cell Biol.* **219**, e201906127 https://doi.org/10.1083/jcb.201906127

85 Chang, C.L. and Liou, J. (2015) Phosphatidylinositol 4,5-bisphosphate homeostasis regulated by Nir2 and Nir3 proteins at endoplasmic reticulum-plasma membrane junctions. *J. Biol. Chem.* **290**, 14289–14301 https://doi.org/10.1074/jbc.M114.621375

86 Gatta, A.T., Wong, L.H., Sere, Y.Y., Calderon-Norena, D.M., Cockcroft, S., Menon, A.K. et al. (2015) A new family of StART domain proteins at membrane contact sites has a role in ER-PM sterol transport. *eLife* **4**, e07253 https://doi.org/10.7554/eLife.07253

87 Murley, A., Sarsam, R.D., Toulmay, A., Yamada, J., Prinz, W.A. and Nunnari, J. (2015) Ltc1 is an ER-localized sterol transporter and a component of ER-mitochondria and ER-vacuole contacts. *J. Cell Biol.* **209**, 539–548 https://doi.org/10.1083/jcb.201502033

88 Naito, T., Ercan, B., Krshnan, L., Trieb, A., Koh, D.H.Z., Wei, F.Y. et al. (2019) Movement of accessible plasma membrane cholesterol by the GRAMD1 lipid transfer protein complex. *eLife* **8**, e51401 https://doi.org/10.7554/eLife.51401

89 Ercan, B., Naito, T., Koh, D.H.Z., Dharmawan, D. and Saheki, Y. (2021) Molecular basis of accessible plasma membrane cholesterol recognition by the GRAM domain of GRAMD1b. *EMBO J.* **40**, e106524 https://doi.org/10.15252/embj.2020106524

90 Ferrari, A., He, C., Kennelly, J.P., Sandhu, J., Xiao, X., Chi, X. et al. (2020) Aster proteins regulate the accessible cholesterol pool in the plasma membrane. *Mol. Cell. Biol.* **40**, e00255-20 https://doi.org/10.1128/MCB.00255-20

91 Sandhu, J., Li, S., Fairall, L., Pfisterer, S.G., Gurnett, J.E., Xiao, X. et al. (2018) Aster proteins facilitate nonvesicular plasma membrane to ER cholesterol transport in mammalian cells. *Cell* **175**, 514–529.e20 https://doi.org/10.1016/j.cell.2018.08.033

92 Trinh, M.N., Brown, M.S., Seemann, J., Vale, G., McDonald, J.G., Goldstein, J.L. et al. (2022) Interplay between Asters/GRAMD1s and phosphatidylyserine in intermembrane transport of LDL cholesterol. *Proc. Natl Acad. Sci. U.S.A.* **119**, e2120411119 https://doi.org/10.1073/pnas.2120411119

93 Wilhelm, L.P., Wendling, C., Vedie, B., Kobayashi, T., Chenard, M.P., Tomasetto, C. et al. (2017) STARD3 mediates endoplasmic reticulum-to-endosome cholesterol transport at membrane contact sites. *EMBO J.* **36**, 1412–1433 https://doi.org/10.15252/embj.201695917

94 Acoba, M.G., Senoo, N. and Claypool, S.M. (2020) Phospholipid ebb and flow makes mitochondria go. *J. Cell Biol.* **219**, e202003131 https://doi.org/10.1083/jcb.202003131

95 Kim, H., Lee, S., Jun, Y. and Lee, C. (2022) Structural basis for mitoguardin-2 mediated lipid transport at ER-mitochondrial membrane contact sites. *Nat. Commun.* **13**, 3702 https://doi.org/10.1038/s41467-022-31462-6

96 Yeo, H.K., Park, T.H., Kim, H.Y., Jang, H., Lee, J., Hwang, G.S. et al. (2021) Phospholipid transfer function of PTPIP51 at mitochondria-associated ER membranes. *EMBO Rep.* **22**, e51323 https://doi.org/10.15252/embr.202051323

97 Fairn, G.D., Hermansson, M., Somerharju, P. and Grinstein, S. (2011) Phosphatidylyserine is polarized and required for proper Cdc42 localization and for development of cell polarity. *Nat. Cell Biol.* **13**, 1424–1430 https://doi.org/10.1038/ncb2351

98 Deng, Y., Rivera-Molina, F.E., Toomre, D.K. and Burd, C.G. (2016) Sphingomyelin is sorted at the trans Golgi network into a distinct class of secretory vesicle. *Proc. Natl. Acad. Sci. U.S.A.* **113**, 6677–6682 https://doi.org/10.1073/pnas.1602875113